Multisystem Inflammatory Syndrome Associated With COVID-19 in Children (MIS-C): A Systematic Review of Studies From India어린이의 COVID-19와 관련된 다기관 염증 증후군(MIS-C): 인도 연구의 체계적인 검토Article Published on 2022-07-152022-09-11 Journal: Indian pediatrics [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] Admissions age article calculate children clinical Clinical features coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids Course COVID-19 database databases derangement disease course disease status Effect feature Features Fever Frequency Future gastrointestinal problem gastrointestinal problems GraphPad GraphPad software Health Organization Immunoglobulin India Inflammatory Inflammatory marker inflammatory markers intensive care Intravenous immunoglobulin IQR Kawasaki disease laboratory parameter Laboratory parameters majority male median MIS-C mortality rate NIH parameter Patient patients ranged reported required review SARS-COV-2 infection Screening Standard deviation syndrome systematic review the disease the mean Therapeutics Treatment was done was used World Health Organization [DOI] 10.1007/s13312-022-2559-5 PMC 바로가기 [Article Type] Article
COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?Observational Study Published on 2022-07-152022-10-04 Journal: PLoS ONE [Category] 임상, [키워드] Admission Care Characteristics Cohort comorbid conditions Complication Computed tomography conducted COVID-19 infection COVID-19 patient Critical Critical care D-dimer levels death demographics determine develop discharge effective ferritin hospitalized patients immunization individual Infection invasive ventilation lab LDH LOS median medical records mortality rate NIV non-invasive ventilation outcome Patient patients Preliminary data presenting Primary outcome Probability procalcitonin profiles proportion prospective observational cohort recruited reduction in required secondary outcome serum severity significantly higher significantly increased Support the patient university vaccinate vaccination with COVID-19 [DOI] 10.1371/journal.pone.0270485 PMC 바로가기 [Article Type] Observational Study
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysisArticle Published on 2022-07-092022-10-06 Journal: EClinicalMedicine [Category] 진단, [키워드] 95% CI adverse event AEs applied benefit cellular therapy China Chinese CNKI Cochrane Library control group Coronavirus disease-19 (COVID-19) COVID-19 Critical database Descriptive analysis development disease category dose doses Efficacy Efficacy and safety Egger Free heterogeneity in-hospital mortality in-hospital mortality rate Innovation less Mesenchymal stem cells Meta-analysis mortality rate MSC MSCs optics original Patient patients with COVID-19 Placebo plan Primary outcome Program reduce mortality Safe Safety Science searched Secondary outcomes significant difference small sample size standard care standard treatment stem cell stromal cell subgroup analysis Support systematic review technology the disease Tianjin Trade Treatment Trial two groups Valley was performed were used Wuhan [DOI] 10.1016/j.eclinm.2022.101545 PMC 바로가기 [Article Type] Article
Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 InfectionSARS-CoV-2 감염에서 회복된 투석 및 신장 이식 환자에서 COVID-19 mRNA 백신 2회 투여 후 항체 반응Article Published on 2022-07-032022-09-12 Journal: Medicina [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Administered administration antibody Antibody Response Antibody titer BNT162b2 vaccine booster dose categories clinical outcomes clinical recovery COVID-19 COVID-19 vaccination Depression develop dose effective Effectiveness evaluate Evidence General population Hemodialysis Humoral immunity IgG level immune immunodepressed patients impacted increased risk Infection kidney kidney transplant recipient Kidney transplantation Laboratory less material Moderna mortality rate mRNA mRNA vaccine mRNA vaccines mRNA-1273 vaccine pandemic Patient Pfizer-BioNTech reached recovered response S1/S2 SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection second dose serology significant increase subject transplantation vaccination Vaccine [DOI] 10.3390/medicina58070893 PMC 바로가기 [Article Type] Article
Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessmentdaclatasvir와 Sofosbuvir 및 COVID-19 환자의 결과: GRADE 평가를 통한 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-07-012022-09-11 Journal: Postgraduate medical journal [Category] 임상, [키워드] Admission certainty of evidence chance clinical clinical pharmacology clinical recovery clinically control group Controlled trial COVID-19 daclatasvir database databases death defined estimate evaluate the effect ICU ICU admission IMV inception increase in Infectious diseases intensive care intensive care unit internal medicine intervention group Invasive mechanical ventilation lower mortality Meta-analysis moderate Mortality mortality rate outcome Patient patients with COVID-19 performed Primary outcome randomised controlled trial reduce mortality rate reduced reported risk ratio risk ratios risk reduction RRs secondary outcome Secondary outcomes sofosbuvir sofosbuvir/daclatasvir Standard of care systematic literature search systematic review Virology [DOI] 10.1136/postgradmedj-2021-140287 PMC 바로가기 [Article Type] Meta-Analysis
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patientsResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] COVID19(2023년), SARS, 신약개발, [키워드] 95% CI addition Admission age anti-inflammatory properties association cardiovascular diseases Chronic kidney disease CKD cohort study condition conditions Corticosteroids COVID COVID-19 COVID-19 infected patients COVID-19 patient COVID19 decrease diabetes evaluated groups hospital Hospitalization hospitalized COVID-19 patients hospitalized patient hypertension ICU ICU admission implementation Inflammatory marker inhibitor intensive care Mortality mortality rate notable Odds ratio outcome proportion Result SARS-CoV-2 severity Sex shown significant difference significantly single-center statin statins statistical analysis Statistics stroke Tehran variable was performed [DOI] 10.1016/j.therap.2021.10.006 [Article Type] Research article
Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trialRandomized Controlled Trial Published on 2022-07-012022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 임상, [키워드] 95% confidence interval atorvastatin COVID-19 decrease duration of hospitalization Effect evaluate the effect FIVE Frequency greater hazard ratio Hospitalization hospitalized patient Hydroxychloroquine ICU intervention group intubation Kaletra® median Mortality mortality rate occurred outcome Patient patients died Pneumonia Probability progression Pulse rate randomized clinical trial Randomized controlled trial randomly divided receiving Sepsis Seven Standard therapy survival Symptom Treatment was performed with COVID-19 [DOI] 10.1002/jmv.27710 PMC 바로가기 [Article Type] Randomized Controlled Trial
Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative studyResearch article Published on 2022-07-012022-10-05 Journal: Research in social & administrative pharmacy : RSA [Category] 임상, [키워드] Anticoagulant Anticoagulants bleeding Care Clinical outcome clinical outcomes complications coronavirus disease COVID-19 discharge dose Efficacy enoxaparin evaluated hospital Hospital stay Hospitalization hypoxia ICU ICU admission in-hospital mortality incidence intensive care involved medication Mild moderate Moderate COVID-19 mortality rate objective outcome Patient patients with moderate Pneumonia Prophylactic Prophylaxis proportion Result rivaroxaban significant difference subcutaneously Thromboprophylaxis thrombotic thrombotic complication Thrombotic events transferred Treatment two groups [DOI] 10.1016/j.sapharm.2022.07.004 [Article Type] Research article
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness케모카인, 가용성 PD-L1 및 면역 세포 저반응은 SARS-CoV-2 중병의 뚜렷한 특징입니다Article Published on 2022-07-012022-09-12 Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome ARDS C-reactive protein CCL17 CCL26 cellular checkpoint pathway chemoattractant comparison coronavirus disease Coronavirus-2 COVID-19 Critical Critically ill patient CRP CXCL10 demographics enrolled feature hyporesponsiveness identify IFN-γ IL-10 IL-17A IL-6 IL-8 immune Immune cell immune signature in vitro Interaction less lymphocyte Migration molecular monocyte mortality rate multisite not significantly different p value Patient patients patients without COVID-19 PD-L1 plasma Pneumonia profile prospective cohort Regulatory SARS-CoV-2 SARS-CoV-2-positive patient SARS-CoV-2-positive patients Sepsis severe respiratory failure severity subject subjects T cell T-cell TNF-α two groups ventilator-free day with COVID-19 [DOI] 10.1152/ajplung.00049.2022 PMC 바로가기 [Article Type] Article
Human versus Artificial Intelligence–Based Echocardiographic Analysis as a Predictor of Outcomes: An Analysis from the World Alliance Societies of Echocardiography COVID StudyResearch article Published on 2022-07-012022-10-05 Journal: Journal of the American Society of Echocardiograph [Category] 바이오마커, [키워드] acute COVID-19 addition all-cause mortality Alliance Analysis artificial artificial intelligence automated Biomarker Cardiac imaging correlation COVID COVID-19 Direct disease echocardiographic echocardiography Ejection fraction enrolled feasibility Follow-up follow-up period had more hospital Human Hypothesis In-hospital left Left ventricular function LVEF machine learning Mortality mortality rate multivariable Odds ratio Outcomes prediction Patient predict Predictive predictor regression analysis Result significantly Society Statistical power transthoracic echocardiography univariable Variability ventricular WASE with COVID-19 [DOI] 10.1016/j.echo.2022.07.004 [Article Type] Research article